Rezolute is trading 12.66% up at $5.25, but no clear company-specific catalyst was identified for August 21, 2026.
- The latest identifiable material update remains the June 2 positive interim upLIFT data.
- Fully enrolled topline results are expected during the second half of 2026.
- That catalyst is not new today, while biotechnology shares are declining, leaving the sharp gain unexplained.